Aktive Positionen von Alan Sokaler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Direktor/Vorstandsmitglied | - | - |
| Comptroller/Controller/Auditor | 02.03.2023 | - |
Karriereverlauf von Alan Sokaler
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Alan Sokaler
- Erfahrung